{
  "created_at": "Tue Jun 08 11:0:36 +0000 2021",
  "id_str": "1402188696833626121",
  "full_text": "The first drug promising to slow the memory-robbing march of Alzheimer's was approved by U.S. health regulators https://t.co/zDZz45ancc",
  "display_text_range": [
    0,
    135
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/zDZz45ancc",
        "expanded_url": "https://on.wsj.com/3cIqC51",
        "display_url": "on.wsj.com/3cIqC51",
        "indices": [
          112,
          135
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 30,
  "favorite_count": 91,
  "possibly_sensitive": false,
  "original_created_at": "Tue Jun 08 09:00:11 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "記憶を奪うアルツハイマー病の進行を遅らせることが期待される最初の薬が、米国の医療当局によって承認されました。https://t.co/zDZz45ancc"
    },
    {
      "locale": "zh",
      "full_text": "第一个有望减缓阿尔茨海默氏症的记忆破坏性进展的药物被美国卫生监管机构批准https://t.co/zDZz45ancc。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "第一個有望減緩阿爾茨海默氏症的記憶破壞性進展的藥物被美國衛生監管機構批准https://t.co/zDZz45ancc。"
    }
  ]
}